2026

Herzien: 16 juli 2026

The Invisible Infarction: A Deep Research Verification of Mechanisms, Diagnosis, and Management in MINOCA

Hoe dit artikel te gebruiken

Medische disclaimer: Dit artikel is uitsluitend voor educatieve doeleinden en is geen medisch advies. Raadpleeg altijd uw arts voor persoonlijk advies.

Eenvoudige taal

Imagine you are lying in a hospital bed. Your chest feels tight, like a heavy weight is sitting on you. It is hard to catch your breath. You feel scared because you are sure you are having a hartinfarct. The doctors move fast. They take you into a special room to look at the pipes of your heart. This test is called an angiogram. It is the standard way doctors check for a heart attack.

A short while later, the doctor returns. He has a look of surprise on his face. He tells you some news that should be good, but it feels wrong. He says, “Your arteries look clear. There are no big clogs. Your heart pipes are open.”

You don’t feel relieved. You know what your body felt. You know the pain was real. This is a terrifying moment for many patients. How can you have a heart attack if the “pipes” are not blocked?

For a long time, doctors were just as confused as the patients. Today, science has an answer. This condition is called MINOCA. That is a long name that stands for “Myocardial Infarction with Non-Obstructive Coronary Arteries.” In simple words, it means you had a real heart attack, but your big heart pipes are at least 50% open. This is what we call the “Invisible Infarction.”

Takeaway 1: Your Heart is Not a Simple Kitchen Pipe

Most people think of the heart like the plumbing in a house. Doctors often call this the “Plumbing Model.” In this way of thinking, your heart pipes are like a kitchen sink. Over many years, grease and junk build up. This junk is called tandplak. Eventually, the pipe gets so full of junk that the water cannot get through. That is how we used to think every heart attack worked.

But the heart is a living, moving part of your body. It is much more complex than a metal pipe. The “Plumbing Model” is too simple. It makes people think that if the pipe is open, the heart must be healthy. MINOCA proves this is wrong.

Think of a garden hose instead of a sink pipe. You might look inside the hose and see no big clogs. But what if the hose suddenly gets a sharp kink? Or what if the inner lining of the hose starts to peel and flap? The water would still stop flowing. If you only looked for a big clog of grease, you would miss the real problem.

Cardiology is currently going through a major change. Doctors used to think cases like yours were just strange accidents. Now, they see them as a specific type of heart trouble that needs its own special care.

For much of modern cardiology, acute myocardial infarction (AMI) has been dominated by a “plumbing model”: atherosclerotic plaque accumulates over years, progressively narrows the coronary lumen, and ultimately ruptures… However, contemporary cardiovascular science has forced a major refinement: a true myocardial infarction can occur even when coronary angiography shows no obstructive stenosis.

This “paradigm shift” means doctors are moving away from the simple “clogged sink” idea. This is an important step for you as a patient. It means if your pipes look clear, the doctor should not stop looking. They should start looking deeper.

Takeaway 2: MINOCA is Not a Final Answer—It’s a Clue

When a doctor says you have MINOCA, it can sound like they have solved the mystery. But it is important to remember that MINOCA is a “working diagnosis.” This means it is a starting point, not a finish line.

Think of a detective at a crime scene. If the detective sees that no windows were broken, he hasn’t caught the thief yet. He just knows how the thief did not get into the house. That is what MINOCA is. It tells the doctor that the heart attack was not caused by a giant, 100% clog in a main pipe.

Calling it MINOCA is the doctor saying, “I know what happened—you had a heart attack—now I need to find out waarom.”

If a doctor tells you your arteries are “normal” and stops there, it can be dangerous. This stops the search for the real cause. It is like a detective giving up because the windows are fine while the thief is still in the house. We must use the MINOCA label as an invitation to keep digging. We need to look for the “fingerprints” left behind by the real cause.

Takeaway 3: The “5% Club” is Bigger Than You Think

You might feel like you are the only one this has happened to. But you are not alone. About 5% to 6% of all heart attacks are MINOCA cases.

That might sound like a small number, but think about how many people have heart attacks every year. Five or six percent means thousands and thousands of people are told their arteries are “clear” even though they are hurting.

This “5% club” has some very specific members. It happens more often in women than in men. It also happens more often in younger patients. In the past, many of these patients were told their chest pain was just stress or “nerves.” Because they didn’t have a “clogged pipe,” they were sent home with no answers.

This is a major health issue. If you feel like you aren’t being heard, remember that thousands of others are in your exact shoes. Knowing these numbers helps us advocate for better care. It proves that this is a real medical condition that doctors must take seriously.

Takeaway 4: You Can Have “Plaque” Without a “Blockage”

There is a big myth that “clear arteries” mean “perfect arteries.” This is almost never true in MINOCA. When a doctor says your arteries are “non-obstructive,” they are using a technical term.

In the medical world, a “blockage” is only called a blockage if it closes the pipe by 50% or more. If the pipe is 20% or 40% full of junk, doctors often say it is “non-obstructive.” But 40% full is still not “normal.”

Think of a pimple on your skin. A pimple is small and does not stop you from moving your arm. But if that pimple “pops” or cracks, it causes a small injury and a scab. The same thing can happen inside a heart pipe. You might have a small bump of plaque that doesn’t block the blood flow much. But if that small bump pops, it creates a tiny blood clot. That clot can cause a heart attack.

By the time the doctor takes a picture of your heart, that tiny clot might have washed away. The pipe looks open again. But the “pimple” is still there. This is why “clear” doesn’t mean “safe.” Even a small amount of plaque can cause big trouble if it is unstable.

Takeaway 5: High-Tech Cameras Reveal the “Invisible” Truth

Standard tests for the heart are like looking at a pipe from across the room. They show if the pipe is open. But they don’t show what is happening inside the walls of the pipe. To see the truth, doctors need better cameras.

A famous study called the HARP study used two high-tech tools:

OCT (Optical Coherence Tomography): This is like a tiny, high-definition camera that goes right inside the heart pipe. It can see the walls of the pipe in amazing detail.
CMR (Cardiac Magnetic Resonance): This is a special MRI for the heart. It shows exactly where the heart muscle was hurt.

When doctors used both of these tests together, they found the real cause of the heart attack in 84.5% of the women they studied! That is a huge success.

One big finding from this study was about “culprit lesions.” This sounds complicated, but it just means the “starting point” of the trouble. The cameras found these starting points in 46.2% of the patients. Some people get this number wrong. They think it only means a piece of plaque burst. But the study showed it’s more than that—it’s any specific spot that caused the heart attack to begin. These tools allow doctors to see what was previously “invisible.”

Takeaway 6: “Clear” Does Not Mean “Safe”

In the past, some doctors used the word “benign” to talk about MINOCA. “Benign” usually means something is not a big deal or won’t hurt you. This was a very big mistake.

MINOCA is a serious medical event. It is a real heart attack. Research shows that people who have a MINOCA heart attack still face risks in the future. They can have more chest pain. They can have another heart attack. They even face a risk of death that is similar to people with “clogged” pipes.

Calling these cases “safe” meant that many patients did not get the medicine or the check-ups they needed. They were sent home and told not to worry. But you should be watchful. If you have been told your arteries are clear but you had a heart attack, you must treat it with respect. It is not a false alarm. It is a real warning sign that your heart needs help.

Takeaway 7: The Four Secret Ways Your Heart Can Fail

If a big clog is not the reason for the heart attack, what is? Doctors have found four main “secret” ways this happens. Standard tests often miss these because they only look for permanent clogs.

Plaque Disruption: This is the “pimple” we talked about. A small piece of plaque cracks or pops. It creates a temporary clot that hurts the heart, then the clot disappears. Standard tests miss this because the clot is often gone by the time the camera is looking.
Heart Cramps (Vasospasm): The heart pipe is a muscle. Sometimes, it has a sudden, intense cramp. It squeezes shut so tight that no blood can get through. Standard tests miss this because the pipe only cramps for a few minutes and then opens back up to look normal.
Small Vessel Trouble (Microvascular Dysfunction): Your heart has big pipes and tiny pipes. Standard tests only see the big ones. Sometimes, the tiny pipes stop working. Standard tests miss this because they are not powerful enough to see the smallest vessels in the heart.
Sudden Tears (SCAD): This is when the inner wall of the slagader actually peels or tears. It is very common in younger women. Standard tests miss this because the tear is inside the wall, and the surface can look smooth and normal on a basic scan.

Conclusion: The Invitation to Look Deeper

The most important thing to take away from this is simple: A clear heart scan is not the end of the story. It is the beginning of a new one.

If your pipes look “clear” but your body tells you that you had a heart attack, do not just go home and forget about it. This is an invitation to look deeper. It means the “usual” cause wasn’t there, so your doctor must look for the “unusual” one.

We must be our own advocates. If a doctor tells you everything is fine, but you know it isn’t, ask for deeper tests like OCT or CMR. These tools can find the truth in over 80% of cases. We must understand that our hearts are living, complex systems, not just simple kitchen plumbing.

When a standard test says one thing, but your body says another, always listen to your body. A clear scan is good news, but finding the real cause is the only way to stay safe for the long haul. Be the detective your heart needs.

Diepe duik

Executive Summary: The Paradigm Shift in Acute Coronary Syndromes

For much of modern cardiology, acute myocardinfarct (AMI) has been dominated by a “plumbing model”: atherosclerotic tandplak accumulates over years, progressively narrows the coronary lumen, and ultimately ruptures, triggering trombose and an abrupt, flow-limiting occlusion. This paradigm remains central to the majority of myocardial infarctions. However, contemporary cardiovascular science has forced a major refinement: a true myocardial infarction can occur even when coronary angiography shows no obstructive stenosis. This clinical entity—myocardial infarction with non-obstructive coronary arteries (MINOCA)—is no longer regarded as an anomaly or exclusionary curiosity, but rather as a heterogeneous ischemic syndrome that requires structured evaluation and mechanism-directed therapy.¹

This report verifies the key mechanisms, definitions, and landmark evidence supporting modern MINOCA care, with particular focus on the 2019 American Heart Association (AHA) Scientific Statement¹ and the Women’s Hartinfarct Research Program (HARP) multimodality imaging study.² The core evidence supports several conclusions with high confidence:

MINOCA is not rare and accounts for approximately 5–6% of MI presentations, with reported ranges varying by population and operational definition¹,⁴;
MINOCA is explicitly framed as a working diagnosis, not a final label¹;
Intravascular imaging (optical coherence tomography, OCT) en cardiac magnetic resonance (CMR) identify a likely mechanism in a high proportion of women with MINOCA (≈84.5% among those undergoing both modalities in HARP)²; and
the frequently cited “46%” statistic from HARP refers to OCT-identified definite or possible culprit lesions, not “46% plaque rupture.”²

Chapter 1: Historical Context and the Modern Definition

1.1 From diagnostic dismissal to structured clinical framework

Historically, patients—particularly women—presenting with chest pain, biomarker elevation, and non-obstructive coronary angiography were variably labeled with ambiguous or dismissive terms. This contributed to under-recognition, inconsistent management, and inadequate secundaire preventie. Contemporary consensus has reversed this approach: MINOCA is now recognized as a genuine MI phenotype encompassing multiple ischemic mechanisms and several clinically important non-ischemic mimics.

The most influential U.S. consensus document is the 2019 AHA Scientific Statement chaired by Tamis-Holland, which formalized a practical definition of MINOCA and emphasized its use as a working diagnosis requiring further investigation rather than a diagnostic endpoint.¹

1.2 The three diagnostic pillars (AHA + Universal Definition alignment)

The AHA statement explicitly aligns MINOCA with the Fourth Universal Definition of Myocardial Infarction.¹,³ Diagnosis requires fulfillment of three pillars:

Pillar 1: A true acute myocardial infarction.
This requires detection of a rise and/or fall in cardiac troponin with at least one value above the 99th percentile upper reference limit, plus evidence of myocardial ischemia, including ischemic symptoms, new ischemic ECG changes, pathological Q waves, imaging evidence of new ischemic myocardial injury, or identification of coronary thrombus.¹,³ The Universal Definition underscores the critical distinction between myocardial injury (non-ischemic mechanisms) and myocardinfarct (ischemic mechanisms).³

Pillar 2: Non-obstructive epicardial coronary arteries.
Non-obstructive disease is pragmatically defined as no coronary stenosis ≥50% in any major epicardial vessel on angiography.¹ The statement acknowledges the limitations of visual angiographic estimation and notes that physiologic assessment (e.g., fractional flow reserve) may be considered in selected cases, but the ≥50% angiographic threshold remains the operational definition.¹

Pillar 3: No alternate diagnosis explaining the presentation.
MINOCA is a label applied after angiography but before exclusion of non-ischemic mimics or systemic causes of troponin elevation. The AHA statement emphasizes ruling out overt alternative diagnoses (e.g., sepsis, pulmonary embolism) and recognizing subtler mimics such as myocarditis of takotsubo syndrome that can resemble MI at presentation.¹,³

Chapter 2: Epidemiology, Demographics, and Why Definitions Matter

2.1 General prevalence and variability

MINOCA prevalence varies substantially depending on cohort selection and diagnostic rigor. The AHA Scientific Statement summarizes MINOCA as occurring in approximately 5–6% of MI patients undergoing angiography, while acknowledging broader ranges across studies.¹ A widely cited systematische literatuurstudie by Pasupathy et al. highlights substantial heterogeneity in reported prevalence and outcomes across international cohorts.⁴

2.2 Sex distribution and clinical implications

MINOCA is consistently reported to occur more frequently in women than in men. The AHA statement notes a disproportionate representation of women among MINOCA cases compared with obstructive MI.¹ Large U.S. registry analyses, including the ACTION Registry–Get With The Guidelines, demonstrate that MINOCA is more common among younger patients and women and provide comparative outcome data by sex and obstructive disease status.⁵

2.3 Clarifying misconceptions about “normal arteries”

A persistent misconception is that MINOCA implies “no plaque” or “completely normal coronary arteries.” This is incorrect. MINOCA explicitly includes patients with mild to moderate aderverkalking, provided no lesion meets the ≥50% stenosis threshold.¹

Importantly, the HARP study does not report a prevalence of “completely normal arteries.” Its primary focus is on imaging-detected mechanisms, not angiographic smoothness rates.² The AHA statement is explicit: MINOCA does not mean normal arteries.¹

Chapter 3: HARP—Unmasking the Invisible With OCT and CMR

3.1 Why HARP was pivotal

The HARP study fundamentally advanced MINOCA research by applying two complementary imaging modalities: OCT to visualize coronary slagader wall pathology and CMR to characterize myocardial injury patterns. This design addressed the central limitation of angiography, which visualizes only the lumen and frequently misses plaque surface disruption, small thrombi, subtle dissections, or transient ischemic mechanisms.²

3.2 Verified enrollment and imaging pipeline

According to the HARP publication:

301 women were enrolled across 16 sites
170 were diagnosed with MINOCA at angiography
145 had OCT images adequate for analysis
116 of those underwent CMR
²

3.3 Correct interpretation of the “46.2%” statistic

HARP reports that a definite or possible culprit lesion was identified by OCT in 46.2% (67/145) of participants.² This refers to any OCT-defined culprit lesion, not plaque rupture alone. Treating this number as “46% plaque rupture” is incorrect and unsupported by the primary publication.

3.4 Multimodality diagnostic yield

Among participants who underwent both OCT and CMR, a likely mechanism for the MI presentation was identified in 84.5% (98/116).² This finding strongly supports the AHA’s framing of MINOCA as a diagnosis that benefits from layered evaluation rather than diagnostic closure.¹,²

Chapter 4: Mechanisms of the “Invisible” Infarction

MINOCA is a phenotype encompassing multiple ischemic mechanisms, as outlined in the AHA Scientific Statement.¹

4.1 Plaque disruption without obstructive stenosis

Plaque rupture or erosion can occur in lesions that never produced ≥50% stenosis. Resulting thrombus may be transient, partially lysed, or embolize distally, leaving a non-obstructive angiogram despite true ischemic injury. The AHA statement highlights plaque disruption as a common mechanism and supports intracoronary imaging when appropriate.¹ Classic IVUS studies provide conceptual support for this mechanism.⁶

4.2 Coronary vasospasm

Intense, transient vasoconstriction of an epicardial artery can produce ischemia and infarction, then resolve before angiography. The AHA statement discusses vasospasm mechanisms and the selective use of provocative testing.¹

4.3 Coronary microvascular dysfunction

Microvascular dysfunction involves impaired regulation of small intramyocardial vessels not visualized on angiography. The AHA statement acknowledges CMD as a potential mechanism and emphasizes uncertainty in determining causality versus consequence in individual patients.¹,³

4.4 Coronary embolism or thrombosis

Embolic or thrombotic events can cause transient obstruction or distal microvascular occlusion with minimal residual epicardial disease. The AHA statement outlines selective evaluation, including thrombophilia testing when appropriate.¹

4.5 Spontaneous coronary artery dissection (SCAD)

SCAD is a critical non-atherosclerotic cause of MI, particularly in younger and middle-aged women. Angiographic appearances may be subtle, and intracoronary imaging can be required in selected cases. The AHA SCAD Scientific Statement provides authoritative guidance, and the MINOCA statement emphasizes careful angiographic review for overlooked SCAD.¹,⁷

Chapter 5: Prognosis—Dispelling the “Benign” Myth

MINOCA is not benign. Although outcomes may be better than in extensive obstructive CAD, patients face meaningful risks of recurrent symptoms, recurrent MI, and mortality.¹ Registry analyses, including ACTION Registry–GWTG studies, provide comparative outcome data and reinforce the need for structured follow-up.⁵ Contemporary clinical reviews emphasize that inconsistent definitions historically contributed to conflicting prognostic estimates.⁸

Chapter 6: Management—From Uniform Treatment to Cause-Directed Care

Randomized trial evidence is limited because many classic MI trials excluded patients without obstructive CAD. The AHA statement therefore emphasizes mechanism-directed therapy supported by physiology and observational data.¹

De SWEDEHEART registry analysis demonstrated associations between statines and renin–angiotensin system blockers and improved long-term outcomes in MINOCA patients, while routine dual antiplatelet therapy showed no clear overall benefit across the heterogeneous cohort.⁹,¹⁰ These findings are observational and hypothesis-generating, consistent with AHA guidance.¹

Conclusion

MINOCA has evolved from diagnostic confusion to a defined clinical framework. The 2019 AHA Scientific Statement establishes MINOCA as an MI phenotype requiring exclusion of mimics and pursuit of a specific ischemic mechanism.¹ The HARP study demonstrates that when OCT and CMR are applied, a likely mechanism can be identified in the majority of women studied (≈84.5%), and that nearly half have an OCT-defined culprit lesion despite non-obstructive angiography.²

The core implication is clear: **a non-obstructive angiogram is not a dismissal—it is an invitation to look deeper.**¹,²,³

Referenties

Transparency Note: This blog post was created with assistance from AI tools. The final content has been carefully reviewed and edited by the author, who is responsible for its accuracy. The information provided is for educational purposes only and does not constitute medical advice.

CuringHeartDisease

Altijd op zoek naar een geneesmiddel
Peter Megdal, PhD